This browser doesn't support Spotify Web Player. Switch browsers or download Spotify for your desktop.

The Price of Innovation

By Tradeoffs

Every time the U.S. tries to rein in rising drug prices, we hear the same thing from pharma: Stymie our profits, and you’ll get less innovation and fewer breakthrough treatments. Does the evidence back up this constant refrain?Guests:Chaitan Khosla, Director of Stanford ChEM-HCraig Garthwaite, Associate Professor of Strategy, Kellogg School of Management at Northwestern UniversityStacie Dusetzina, Associate Professor of Health Policy, Vanderbilt UniversityCheck out the research for yourself and learn more on our website:  As they say in health care, there’s no such thing as a free podcast. Support our show: Follow us on Twitter:  For information regarding your data privacy, visit

Listen to The Price of Innovation now.

Listen to The Price of Innovation in full in the Spotify app